Center of Excellence in Vaccine Research and Development,
Chulalongkorn University (Chula VRC)
Chula VRC was formally established in 2017 under the supervision of Professor Kiat Ruxrungtham. We consists of faculty staff and researchers with common interest in vaccine research and development to work together and share their knowledge and experience leading to the strength of the team. We focuses not only on vaccines against infectious diseases, such as HIV infection, dengue fever, leptospirosis, and emerging infections including novel corona virus disease (COVID-19) but also vaccines against non-infectious diseases including house dust mite allergy.
We are Chula VRC
Dengue Team
HIV Team
House Dust Mite Team
Leptospirosis Team
COVID-19 Team
Key Contact Persons
Latest News & Events
เปิดรับสมัครอาสาสมัครสุขภาพดีสำหรับโครงการ ChulaCov19 BNA159 mRNA vaccine คุณสมบัติ อายุ
A COVID-19 vaccine made by BioNet-Asia in Ayutthaya, Thailand, should be cheaper than the
Dr.Chanchai Sittipunt, Dr.Nakorn Premsri, Dr.Suthipong Watcharasin and Dr.Kiat Ruxrungtham greetings to three Prince Mahidol Award 2021 laureates
Amid a global shortage of vaccines and a new wave of COVID-19 infections, some countries in Southeast Asia are rushing to develop their own coronavirus shots.
COVID19 Vaccine Tracker – Chulalongkorn University: ChulaCov19
The research team behind the development of a local mRNA Covid-19 vaccine on Monday asked the government to help finance the project
